The Disease Biology Generative AI Platform for Pharma R&D
We built ASCEND, a science-first, GenAI assistant designed to unravel disease biology.
ASCEND acts as a co-pilot for scientists, guiding them through the complexities of research. It elevates biology-related decision-making and uncovers novelty while increasing experimental productivity.
ASCEND is powered by a knowledge graph and ontological knowledge base that acts as an evidence map of disease biology. ASCEND leverages cutting age multi-modal AI to decode, harmonize and elevate the quality of massive amounts of data from scientific literature including closed access, preprints, patents, clinical data, ontological and third-party data source, in-sitro insights, internal pharma data (historical wet lab results) to understand the underlying mechanisms of diseases and the experiments behind those insights. ASCEND then leverages this data to guide scientists to generate the best ideas and the ideal experimental path to test them.
Why we are different
Data Foundation
Access to the most comprehensive biomedical dataset including closed access papers, patents, preprints and third party data.
Scalable Enterprise-Grade Software
Not just a model or graph, scalable enterprise-grade software solution to support workflows that have never been mapped before.
Biology-Specific Multimodal AI
Multimodal biological LLMs focused on understanding experiments from both text and figures. Powerful GenAI without hallucinations and with scientific explainability.
Internal Data Integrations
Integration of internal pharma data (ELNs, sharepoints, materials) across all TAs with enterprise-grade security and service.
Science First
Not just a technology company. Science-first solution with scientific support and onboarding. Over 100 scientists working hand-in-hand with over 100 engineers and AI experts.
Investors
In the News
Building the Disease Biology Generative AI Platform for Pharma R&D
